Moderna, Inc. (0QF)
XETR
Closed
Aug 24, 2026
Day's Range
111.4252 wk Range
19.37Overview - 0QF - Moderna, Inc.
Key Statistics
Valuation
Enterprise Value
41.08B
P/E (Trailing)
‪-17.03‬
PEG Ratio
‪2.26‬
Price / Sales (TTM)
‪23.31‬
Price / Book
‪8.96‬
EV / EBITDA
‪-21.90‬
Profitability
Gross Margin
‪34.96%‬
Profit Margin
‪-141.42%‬
Operating Margin
‪-557.93%‬
Return on Assets
‪-13.25%‬
Return on Equity
‪-38.99%‬
Ownership
Shares Outstanding
399.00M
Float
372.26M
Held by Insiders
‪7.31%‬
Held by Institutions
‪80.46%‬
Price stats
Beta
‪0.89‬
50-Day Avg
‪57.62‬
200-Day Avg
‪42.17‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 0QF - Moderna, Inc.
Peers - 0QF - Moderna, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XETR.
- 0QFXETRModerna, Inc.51.94BMarket Cap+83.00%52-week change-17.92P/E (Trailing)‪-141.42%‬Profit Margin
- ANLXETRAnalog Devices, Inc.156.54BMarket Cap+34.61%52-week change44.45P/E (Trailing)‪29.78%‬Profit Margin
- 22UAXETRBioNTech SE25.54BMarket Cap+7.30%52-week change157.87P/E (Trailing)‪-63.63%‬Profit Margin
- BBZAXETRBB Biotech AG3.28BMarket Cap-4.04%52-week change13.32P/E (Trailing)‪127.31%‬Profit Margin
- B72XETRAtaiBeckley Inc.2.39BMarket Cap+46.88%52-week change-2.22P/E (Trailing)‪0.00%‬Profit Margin
- BV3XETRBavarian Nordic A/S1.81BMarket Cap+6.58%52-week change11.74P/E (Trailing)‪19.70%‬Profit Margin
- AYJXETRValneva SE561.35MMarket Cap-33.31%52-week change70.98P/E (Trailing)‪-110.29%‬Profit Margin
Profile Summary - 0QF - Moderna, Inc.
About
Moderna, Inc. is a biotechnology company specializing in the research, development, and provision of messenger RNA (mRNA) medicines in the United States, Europe, and internationally. Its primary function centers on creating innovative therapeutics and vaccines using mRNA technology, targeting a broad spectrum of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
